TherapeuticsMD
TXMD
TXMD
131 hedge funds and large institutions have $44M invested in TherapeuticsMD in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 51 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 33
55% less capital invested
Capital invested by funds: $98.2M → $44M (-$54.1M)
Holders
131
Holding in Top 10
–
Calls
$438K
Puts
$208K
Top Buyers
| 1 | +$433K | |
| 2 | +$339K | |
| 3 | +$322K | |
| 4 |
D.E. Shaw & Co
New York
|
+$313K |
| 5 |
AMG
Asset Management Group
Stamford,
Connecticut
|
+$254K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$755K | |
| 3 | -$727K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$621K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$323K |